Leukocyte interferon alpha early retreatment for child a HCV genotype 1b-infected cirrhotics intolerant to pegylated interferons

Infection

Volumn 37, Issue 3, 2009, Pages 210-215

  Cacopardo, B ^a   Nunnari, G ^a   Benanti, F ^a   Cappellani, A ^a   Onorante, A ^a   Caltabiano, E ^a   Russo, R ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON A; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; ALPHA INTERFERON; ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2A; PEGINTERFERON ALFA-2B;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTHRALGIA; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; CYTOPENIA; DEMOGRAPHY; DEPRESSION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FEVER; GENOTYPE; HEADACHE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INJECTION SITE INFLAMMATION; LEUKOPENIA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; OUTCOME ASSESSMENT; PATIENT INFORMATION; RETREATMENT; THERAPY EFFECT; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; DRUG COMBINATION; GENETICS; MIDDLE AGED; VIROLOGY; VIRUS LOAD;

ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; INTERFERON-ALPHA; LIVER CIRRHOSIS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN; TREATMENT OUTCOME; VIRAL LOAD;

EID: 67650251886     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-008-8164-2     Document Type: Article

References (21)

1. A. Alberti L. Chemello L. Benvegnu 1999 Natural history of hepatitis C J Hepatol 31 17 24
2. T. Poynard J. McHutchison G.L. Davis R. Esteban-Mur Z. Goodman B. Bedossa J. Albrecht 2000 FIBROVIRC Project Group Impact of interferon alfa 2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C Hepatology 32 1131 1137
3. M.W. Fried M.L. Shiffman K.R. Reddy C. Smith G. Marinos F.L. Goncales Jr D. Haussinger M. Diago G. Carosi D. Dhumeaux A. Craxi A. Lin J. Hoffman J. Yu 2002 Peginterferon alfa2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 975 982
4. M.P. Manns J.G. McHutchison S.C. Gordon V.K. Rustgi M. Shiffman R. Reindollar Z.D. Goodman K. Koury M. Ling J.K. Albrecht 2001 PegInterferon alfa2b in combination with ribavirin compared to interferon alfa2b plus ribavirin for initial treatment of chronic hepatitis C. Results of a randomized trial Lancet 358 958 965
5. J. Heathcote M.L. Shiffman W.J. Cooksley G.M. Dusheiko S.S. Lee L. Balart R. Reindollar R.K. Reddy T.L. Wright A. Lin J. Hoffman J. De Pamphilis 2000 Peginterferon alfa2a in patients with chronic hepatitis C and cirrhosis N Engl J Med 343 1673 1680
6. T. Poynard J. McHutchison M. Manns C. Trepo K. Lindsay Z. Goodman M.H. Ling J. Albrecht 2002 Impact of pegylated interferon alfa 2b and ribavirin on liver fibrosis in patients with chronic hepatitis C Gastroenterology 122 1303 1313
7. M.W. Russo M.W. Fried 2003 Side effects of therapy for chronic hepatitis C Gastroenterology 124 1711 1719
8. B. Cacopardo F. Benanti G. Brancati F. Romano A. Nunnari 1998 Leukocyte interferon alpha retreatment for chronic hepatitis C patients previously intolerant to other interferons J Viral Hepat 5 333 339
9. C. Cagnoni D. Pancotti G. Carrara 2000 Management of patients with HCV infection poorly tolerant to recombinant interferon alpha Hepatogastroenterology 47 199 203
10. R.G. Knodell K.G. Ishak W.C. Black T.S. Chen R. Craig N. Kaplowitz T.W. Kiernan J. Wollman 1981 Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1 431 5
11. J.M. Moreno Planas E. Rubio Gonzales E. Boullosa Grana A. Garrido Botella C. Barrios Peinado J.L. Lucena Poza M. Jimenez Garrido V. Sanchez Turrion V. Cuervas-Mons Martinez 2005 Effectiveness of pegylated interferon and ribavirin in patients with liver HCV cirrhosis Transplant Proc 37 1482 1483
12. A. Abergel C. Hezode V. Leroy K. Barange J.P. Bronowicki A. Tran L. Alric L. Castera P.H. Bernard C. Henquell H. Lafeuille S. Ughetto C. Darcha M. Chevallier N. Martineau S. Dubost K. Randl D. Dhumeaux G. Bommelaer C. Bonny French multicenter study group 2006 Peginterferon alpha-2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha-2b J Viral Hepat 13 811 820
13. E. Dieperink M. Willebring S.B. Ho 2000 Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review Am J Psychiatry 157 867 876
14. T.L. Wright 2002 Treatment of patients with hepatitis C and cirrhosis Hepatology 36 S185 S194
15. S. Tripi M. Soresi G. Di Gaetano A. Carroccio L. Giannitrapani O. Vuturo G. Di Giovanni G. Montalto 2003 Leukocyte interferon alfa for patients with chronic hepatitis C intolerant to other alpha interferons BioDrugs 17 201 205
16. M. Malaguarnera S. Restuccia G. Trovato R. Siciliano M. Motta B. Trovato 1995 Treatment with alpha interferons in patients with chronic hepatitis C. A meta-analysis Clin Drug Invest 5 141 149
17. A. Vaccaro M. Giunta A. Lo Iacono A. Craxì 1997 Retreatment with leukocyte interferon of chronic hepatitis C patients non responders to recombinant interferon J Hepatol 26 197(abstract)
18. G.C. Viscomi 1995 Human leukocyte interferon alpha: structure, pharmacology and therapeutic applications Med Res Rev 5 445 478
19. S. Fagiuoli S. Pevere F. Minniti U. Livi A.L. Caforio R. Naccarato M. Chiaramonte 2003 Natural leukocyte interferon alpha for the treatment of chronic viral hepatitis in heart transplant recipients Transplantation 75 982 986
20. A. Benci M. Caremani D. Menchetti M. Sasdelli P.B. Giusti 1998 Low dose leukocyte interferon alpha therapy in dialyzed patients with chronic hepatitis C Curr Med Res Opin 14 141 144
21. A. Gattoni C. Romano A. Cecere R. Caiazzo P. Grima P. Altucci 1996 Efficacy of human leukocyte interferon treatment in elderly patients with hepatitis C virus-related chronic liver disease Arch Gerontol Geriatr 5 305 312